Global Health Matters

27 April 2017 - By Thomas B. Cueni
Over the course of my lifetime, human lifespan extended by three decades.  Today we hope to lead healthy lives well into our 80s. Now I have to declare a vested interest in this topic:  I am an aspiring role model for active and healthy ageing (I’m past 60 and look ...
Read More
25 April 2017 - By Thomas B. Cueni
As we look forward to hosting the Geneva Pharma Forum during current World Immunization Week, finding solutions to pre-empt or mitigate vaccine shortages is top-of-mind here at IFPMA and for our members. What’s more, recently the first Access to Vaccines Index (ATVI) was published – a set of report cards ...
Read More
21 April 2017 - By Thomas B. Cueni
After 30 years in the world of policymaking and business, there is not much that can faze me; but it is fair to say that nothing could have prepared me for meeting Agnes. This has been a week when Geneva played host to ministers, scientists, WHO officials, philanthropists and business ...
Read More
Angkor Thom. Siem Reap Cambodia
7 April 2017 - By Thomas B. Cueni
The name Kantha Bopha is well known in Switzerland. Beat Richner, pediatrician, cello player, and savvy fundraiser, has been working there tirelessly for over 20 years on his life-long project. He had already worked at the Children's Hospital in Phnom Penh in the early 70’s, then the terror of the ...
Read More
4 April 2017 - By Thomas B. Cueni
Animal testing has been and will remain controversial. Whereas most people accept the need to test new medicines or vaccines on laboratory animals before they are authorized for human use, it is also widely accepted that there is a need to strike the right and careful balance between expected benefit ...
Read More
20 March 2017 - By Thomas B. Cueni
It is quite amazing how health policy discussions are often held in a distorted and simplified manner. Nowhere does this apply more than in discussions on drugs and the pharmaceutical industry. Although a large portion of public health spending is accounted for by hospitals, doctors, other health care personnel, and ...
Read More
16 March 2017 - By Thomas B. Cueni
(This is a re-posting that was first published on Monday 13 March in the Basler Zeitung) ‘Vets are expensive. Antibiotics are cheap.’ In a nutshell, this was a quote extracted from last week’s BBC report of the growing global problem of antimicrobial resistance highlighting the plight of overuse of antibiotics on ...
Read More
9 March 2017 - By Thomas B. Cueni
Costs of cancer drugs have risen significantly in Switzerland over the past ten years, from an estimated CHF 445 million to CHF 775 million at ex-factory prices. Bearing in mind future combination treatments in immune-oncology, treatments which are likely to bring from now on unhoped for outcomes, it is timely ...
Read More
27 February 2017 - By Thomas B. Cueni
We need an informed societal debate on how much prolonging life should be allowed to cost (Note to our readers: This is a re-posting that was first published on Monday 27 February in the Basler Zeitung) Recently, the Secretary of Health for the Swiss canton of Zurich, Thomas Heiniger, called for ...
Read More
3 February 2017 - By Laetitia Bigger
In the wake of WEF Davos, there is consensus more than ever that the private sector has a role to play in achieving the 2030 Sustainable Development Goals. From investment opportunities to research capabilities, collective ambitions to sharing information, many sectors see the value of coalitions and opportunities for the ...
Read More
25 November 2016 - By Gerry Elsdon
  Please click on the image above for this must watch video! It’s universally agreed that patients should be able to expect medicines and vaccines to be available when they need them. Yet in some parts of the world, access to high-quality, safe, and efficient treatments can be a cumbersome/awkward ...
Read More
1 November 2016 - By Matthew Downham, PHD
Pharmacists’ role in flu prevention According to recent World Health Organization (WHO) data, in South America flu and other respiratory viruses declined in most countries. Overall, taking the flu shot is the best way to avoid the flu. When fewer people get the vaccine, the virus spreads more quickly, meaning more people ...
Read More
7 October 2016 - By Dr Konji Sebati
Since its inception in 1980, the International Conference of the Drug Regulatory Authorities (ICDRA) represents a major platform for WHO and drug regulatory authorities across its member states, in their efforts to harmonize regulation and improve the safety, efficacy, and quality of medicines. The focus of this year’s ICDRA Conference ...
Read More
3 October 2016 - By John Kalland
Insights and Perspectives from the IFPMA and IFPW “Shaping a Sound Supply Chain Ecosystem” Panel Discussion at the 2016 Global Health Forum, 21 April 2016. Moderated by Sukana Virji, News Editor, Scrip Intelligence and featuring panelists: John Kallend, Sr. Vice President, Director of Manufacturer Relations and Services, Walgreens Boots Alliance ...
Read More
19 September 2016 - By Eduardo Pisani
This blog was originally posted on OECD Insights Antibiotics have made modern medicine possible. Before the discovery of penicillin in 1928 and the recognition of its therapeutic potential, there were few tools doctors could use when patients came to them with common or minor infections from simple paper cuts. Today, ...
Read More